Cargando…
Inhibition of transforming growth factor α (TGF-α)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868
The modulating effects of the epidermal growth factor (EGF) receptor-specific tyrosine kinase inhibitor ZM 252868 on cell growth and signalling have been evaluated in four ovarian carcinoma cell lines PE01, PE04, SKOV-3 and PE01(CDDP). Transforming growth factor α (TGF-α)-stimulated growth was compl...
Autores principales: | Simpson, B J B, Bartlett, J M S, Macleod, K G, Rabiasz, G, Miller, E P, Rae, A L, Gordge, P, Leake, R E, Miller, W R, Smyth, J, Langdon, S P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362251/ https://www.ncbi.nlm.nih.gov/pubmed/10098742 http://dx.doi.org/10.1038/sj.bjc.6690175 |
Ejemplares similares
-
Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cells.
por: Bartlett, J. M., et al.
Publicado: (1992) -
Growth control by epidermal growth factor and transforming growth factor-alpha in human lung squamous carcinoma cells.
por: Rabiasz, G. J., et al.
Publicado: (1992) -
12-O-tetradecanoylphorbol 13-acetate induced differentiation in human lung squamous carcinoma cells.
por: Rabiasz, G. J., et al.
Publicado: (1992) -
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer.
por: Bartlett, J. M., et al.
Publicado: (1996) -
Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 (‘Iressa’)
por: Sewell, J M, et al.
Publicado: (2002)